CMLD010509 (SDS-1-021) is a highly specific inhibitor of the oncogenic translation program in multiple myeloma (MM), targeting key oncoproteins such as MYC, MDM2, CCND1, MAF, and MCL-1; it exhibits potent and selective translation inhibition via an eIF4E phosphorylation-independent mechanism, induces apoptosis, and shows IC50 values below 10 nM in most MM cell lines.